NU 13H05: A Phase Ib Trial of Oncoquest-CLL Vaccine for Treatment-Naive Patients With Chronic Lymphocytic Leukemia
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 16 Jan 2019
Price : $35 *
At a glance
- Drugs Chronic lymphocytic leukaemia vaccine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- Sponsors XEME Biopharma
- 08 Jan 2019 Planned End Date changed from 1 Dec 2017 to 1 Jan 2022.
- 08 Jan 2019 Planned primary completion date changed from 1 Dec 2017 to 1 Jan 2021.
- 02 Mar 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017, according to ClinicalTrials.gov record.